Subsets of adult cancers also overexpress IGF2, including 20% of hepatocarcinoma [7], 40% of colon carcinoma, 90% of liposarcoma [8], and also adrenocortical carcinoma [9]. The gene discussed is IGF2; the disease is adrenal cortex carcinoma.